V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20114409 | 20087271 | 1.94 | 49.3 | 03 | 2019-04-07 | 2019-04-13 | IBRUTINIB | 02 | N | BORTEZOMIB | 100449958 |
| 20114769 | 20087273 | 1.61 | 66.1 | null | 2019-09-27 | 2019-10-03 | OXALIPLATIN | 01 | N | CHLORAMBUCIL + RITUXIMAB | 101262332 |
| 20115021 | 20087276 | 1.78 | 56.1 | 03 | 2021-04-26 | 2021-05-01 | Capecitabine + Streptozocin | 02 | N | PEMBROLIZUMAB | 100795971 |
| 20115098 | 20087277 | null | 68.6 | Neo-adjuvant (N) | 2017-02-16 | 2017-02-24 | BUSULFAN | 02 | N | BUSULPHAN | 100657270 |
| 20115264 | 20087279 | null | null | 03 | 2018-05-17 | 2018-05-20 | NEO-AEGIS TRIAL | 01 | N | GEMCITABINE + PACLITAXEL | 100772298 |
| 20115270 | 20087280 | 1.78 | 56.1 | 03 | 2015-02-23 | 2017-09-27 | IBRUTINIB | 01 | N | HYDROXYCARBAMIDE | 100162654 |
| 20115341 | 20087281 | 1.64 | 79.8 | Adjuvant (A) | null | 2019-08-13 | GO2 TRIAL | 01 | N | ABVD | 101484039 |
| 20115411 | 20087282 | 0 | 13.5 | 03 | 2022-01-07 | 2022-01-07 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | N | LENALIDOMIDE | 101627892 |
| 20115466 | 20087283 | 1.79 | 59.8 | Palliative (P) | 2018-10-30 | 2018-11-04 | Cape + Cetuximab +Irinotecan - Load | N | N | PHITT B OR C CISPLATIN | 101819993 |
| 20115483 | 20087284 | 1.75 | 110 | Palliative (P) | null | 2018-03-25 | Paclitaxel 7 day | 02 | N | FLUOROURACIL + RT | 100547672 |
| 20115510 | 20087285 | 1.67 | 56.8 | null | 2016-09-15 | 2016-09-28 | Capecitabine+Cisplatin+Streptozocin | 02 | N | RUXOLITINIB | 101634179 |
| 20115640 | 20087287 | 1.49 | 93.3 | Palliative (P) | null | 2019-03-27 | Venetoclax | N | N | GEMCARBO | 100971912 |
| 20115685 | 20087288 | null | 79.4 | null | null | 2019-01-15 | NEO-AEGIS TRIAL | 01 | N | SCOPE2 TRIAL | 100099316 |
| 20115739 | 20087289 | 1.65 | 74 | Adjuvant (A) | 2019-02-11 | 2019-02-25 | IPILIMUMAB + NIVOLUMAB | N | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101019837 |
| 20115755 | 20087290 | 1.85 | 48.2 | 03 | 2020-04-04 | 2020-04-04 | FCarboSt | 02 | N | EVEROLIMUS | 100404117 |
| 20115818 | 20087291 | 1.5 | 64.9 | 03 | 2019-07-16 | 2019-07-16 | Irinotecan | 01 | Y | BEVACIZUMAB + CAPECITABINE + OXALIPLATIN | 100922070 |
| 20115859 | 20087292 | 1.6 | 66.7 | Palliative (P) | 2015-05-04 | 2015-05-21 | Cisplatin + Fluorouracil + Streptozocin | null | N | LENALIDOMIDE | 100803512 |
| 20115951 | 20087294 | null | null | null | 2016-10-22 | 2016-10-22 | OXALIPLATIN + MDG + PANITUMUMAB | null | N | CISPLATIN + TEYSUNO | 100828512 |
| 20116024 | 20087295 | 1.66 | 67.2 | Palliative (P) | 2017-06-20 | 2017-06-20 | Capecitabine + Streptozocin | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100340681 |
| 20116141 | 20087296 | 1.51 | 80 | Adjuvant (A) | 2016-08-18 | 2016-08-18 | IBRUTINIB | 01 | N | PACLITAXEL | 100923439 |
| 20116147 | 20087297 | 1.73 | 94 | 03 | 2019-02-28 | 2019-03-24 | Capecitabine + Streptozocin | 01 | N | MITOMYCIN | 101871114 |
| 20116335 | 20087298 | null | 53 | Palliative (P) | 2019-02-19 | 2019-02-22 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | NIVOLUMAB | 100977238 |
| 20116391 | 20087299 | 1.67 | 62.8 | Palliative (P) | 2018-06-23 | 2018-07-14 | null | N | N | PACLITAXEL | 101695215 |
| 20116709 | 20087300 | 0 | 0 | 03 | 2018-11-30 | 2018-11-30 | CHOP R - 21 days | 02 | N | NAB-PACLITAXEL | 100178598 |
| 20116757 | 20087301 | 1.71 | 72.9 | Palliative (P) | 2019-12-09 | 2020-02-19 | CARBOPLATIN + GEMCITABINE | 02 | N | HYDROXYCARBAMIDE | 100521669 |
| 20116761 | 20087302 | 1.71 | 67 | 03 | 2019-09-29 | 2019-09-29 | Gemcitabine + Paclitaxel | 02 | N | IBRUTINIB | 100335788 |
| 20116780 | 20087303 | 1.7 | 88.15 | 03 | 2017-10-04 | 2017-10-12 | PHITT Trial | 02 | N | PANITUMUMAB | 101398674 |
| 20116819 | 20087304 | null | null | 03 | 2016-05-20 | 2016-06-10 | null | 02 | N | OXALIPLATIN | 100059391 |
| 20116834 | 20087305 | 1.59 | 74 | 03 | 2017-04-09 | 2017-04-24 | Cisplatin + Fluorouracil + RT 5day | 02 | N | BALLAD TRIAL | 100715683 |
| 20116842 | 20087306 | 1.63 | 60.1 | 03 | 2017-05-24 | 2017-06-01 | LIPOSOMAL DAUNORUBICIN + CYTARABINE (Vyxeos) | null | N | IBRUTINIB | 101536116 |
| 20116847 | 20087307 | 1.6 | 45.6 | Adjuvant (A) | 2018-04-09 | 2018-04-16 | Cisplatin +FU +Trastuzumab - Load | 02 | N | LIPOSOMAL DOXORUBICIN | 101680672 |
| 20116918 | 20087308 | 1.79 | 76.15 | Palliative (P) | null | 2019-05-16 | IBRUTINIB | 01 | N | CABAZITAXEL | 100663476 |
| 20117027 | 20087309 | 1.55 | 59.1 | null | 2018-01-17 | 2018-01-18 | Irinotecan | 02 | N | LETROZOLE + PALBOCICLIB | 101790858 |
| 20117132 | 20087310 | 1.69 | 68 | Palliative (P) | 2017-10-19 | 2017-10-19 | null | 01 | N | PANITUMUMAB | 101176873 |
| 20117305 | 20087312 | 1.71 | 64.25 | Palliative (P) | 2017-04-07 | 2017-04-14 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100972844 |
| 20117314 | 20087313 | 1.76 | 60.2 | Palliative (P) | 2017-08-26 | 2017-09-09 | BCG Intravesical | 01 | N | RITUXIMAB | 101081573 |
| 20117542 | 20087314 | 1.62 | 95.5 | null | 2016-03-14 | 2016-03-16 | CHOP-R + CYTARABINE HIGH DOSE | N | N | TIPIRACIL + TRIFLURIDINE | 100225491 |
| 20117565 | 20087315 | 1.73 | 68 | 03 | 2017-12-27 | 2017-12-27 | null | 02 | N | POMALIDOMIDE | 100260787 |
| 20117611 | 20087316 | null | null | Palliative (P) | 2018-04-23 | 2018-05-15 | Carboplatin + Vinorelbine IV | 02 | N | BORTEZOMIB | 101616622 |
| 20117635 | 20087317 | 1.73 | 75.2 | null | null | 2019-02-22 | BCG Intravesical | N | N | PHITT C SIOPEL-3HR | 100543798 |
| 20117638 | 20087318 | 1.77 | 63 | Adjuvant (A) | 2019-04-18 | 2019-04-27 | Chlorambucil | 02 | null | CVD | 100909407 |
| 20117727 | 20087319 | 1.84 | 50.3 | Curative (C) | 2020-06-16 | 2020-06-16 | CARBOPLATIN + FLUOROURACIL | 02 | N | BENDAMUSTINE + RITUXIMAB | 100676526 |
| 20117749 | 20087320 | null | null | Adjuvant (A) | 2018-12-09 | 2018-12-16 | Cisplatin +FU +Trastuzumab - Load | 02 | null | CARBOPLATIN + FLUOROURACIL | 100194076 |
| 20117837 | 20087322 | 1.69 | 64 | null | 2018-07-24 | 2018-08-03 | Carboplatin + Docetaxel | 02 | N | RITUXIMAB | 100282376 |
| 20117970 | 20087323 | 1.64 | null | 03 | 2019-12-10 | 2019-12-11 | null | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100370515 |
| 20117981 | 20087324 | 1.68 | 89.4 | Palliative (P) | 2018-12-01 | 2018-12-01 | null | 02 | N | RALTITREXED | 101145410 |
| 20118033 | 20087325 | 1.76 | 77.4 | 03 | 2019-12-07 | 2019-12-16 | ESPAC-4 TRIAL | 02 | N | CISPLATIN + DOXORUBICIN | 101477150 |
| 20118147 | 20087326 | 1.73 | 94.4 | Palliative (P) | 2019-03-24 | 2019-04-05 | CHOP R - 21 days | null | N | NAB-PACLITAXEL | 101830388 |
| 20118311 | 20087327 | 1.84 | 78 | null | 2020-09-01 | 2020-09-04 | PEMBROLIZUMAB | 02 | null | GEMCITABINE + PACLITAXEL | 100792469 |
| 20118474 | 20087328 | 1.71 | 96.3 | null | null | 2018-02-11 | CARBOPLATIN + TEYSUNO | 2 | N | PLATO TRIAL | 101224940 |